KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $12.37 $15.59 Friday, 26th Apr 2024 URGN stock ended at $14.15. This is 2.39% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 4.60% from a day low at $13.69 to a day high of $14.32.
90 days $12.37 $19.87
52 weeks $8.69 $24.13

Historical UroGen Pharma Ltd prices

Date Open High Low Close Volume
Aug 16, 2023 $22.33 $23.70 $21.44 $21.47 400 477
Aug 15, 2023 $22.84 $24.13 $22.29 $22.36 479 325
Aug 14, 2023 $21.91 $22.75 $21.29 $22.64 508 976
Aug 11, 2023 $21.37 $22.58 $20.93 $22.16 532 557
Aug 10, 2023 $21.18 $21.89 $20.21 $21.21 518 265
Aug 09, 2023 $20.80 $21.83 $20.61 $20.70 447 453
Aug 08, 2023 $19.74 $21.08 $19.70 $20.84 443 533
Aug 07, 2023 $20.68 $21.35 $19.53 $20.00 907 514
Aug 04, 2023 $20.07 $20.80 $19.68 $20.68 416 612
Aug 03, 2023 $18.83 $20.15 $18.82 $19.85 539 323
Aug 02, 2023 $20.50 $20.89 $18.66 $18.99 1 005 132
Aug 01, 2023 $21.66 $21.90 $17.85 $20.30 1 744 820
Jul 31, 2023 $22.25 $22.46 $20.71 $21.66 1 449 507
Jul 28, 2023 $16.53 $23.93 $16.05 $22.61 7 881 685
Jul 27, 2023 $9.32 $18.10 $8.86 $17.89 9 298 464
Jul 26, 2023 $8.86 $9.35 $8.69 $9.01 221 643
Jul 25, 2023 $9.10 $9.10 $8.71 $8.84 133 030
Jul 24, 2023 $9.64 $9.64 $9.05 $9.09 191 941
Jul 21, 2023 $10.18 $10.19 $9.26 $9.29 114 949
Jul 20, 2023 $9.78 $10.33 $9.61 $10.14 253 251
Jul 19, 2023 $9.41 $9.82 $9.27 $9.74 95 354
Jul 18, 2023 $9.27 $9.83 $9.18 $9.35 175 900
Jul 17, 2023 $9.20 $9.56 $9.20 $9.40 139 640
Jul 14, 2023 $8.99 $9.29 $8.79 $9.19 133 179
Jul 13, 2023 $9.54 $9.59 $8.83 $8.99 319 868
Click to get the best stock tips daily for free!

About UroGen Pharma Ltd

UroGen Pharma Ltd UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead product candidate is UGN-102, which is in Phase III clinical trials for the treatment of several forms... URGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT